Anesthetic management problems posed by therapeutic advances: 3. Beta-adrenergic blocking drugs.
D000316:Adrenergic alpha-Agonists / Q000502:physiology; D000317:Adrenergic alpha-Antagonists / Q000502:physiology; D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use; D000758:Anesthesia / Q000009:adverse effects*; D001024:Aortic Valve Stenosis / Q000188:drug therapy; D001145:Arrhythmias, Cardiac / Q000188:drug therapy; D003327:Coronary Disease / Q000188:drug therapy; D006801:Humans; D006973:Hypertension / Q000188:drug therapy; D006980:Hyperthyroidism / Q000188:drug therapy; D010673:Pheochromocytoma / Q000188:drug therapy; D013514:Surgical Procedures, Operative; D013565:Sympatholytics / Q000627:therapeutic use*; D013566:Sympathomimetics / Q000627:therapeutic use*; D014652:Vascular Diseases / Q000188:drug therapy
D000316:Adrenergic alpha-Agonists; D000317:Adrenergic alpha-Antagonists; D000319:Adrenergic beta-Antagonists; D013565:Sympatholytics; D013566:Sympathomimetics